<DOC>
	<DOC>NCT01260168</DOC>
	<brief_summary>The objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer. Another objective is to provide anonymous, clinically characterized specimens for a bio-repository for future colorectal cancer-related test development.</brief_summary>
	<brief_title>Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies</brief_title>
	<detailed_description>Patients who have been recently diagnosed with colo-rectal cancer or pre-cancer will be asked to submit a stool sample(s)(at least 7 days AFTER colonoscopy) and will have the option of submitting blood and tissue samples for future colo-rectal cancer-related test development.</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<criteria>1. Subject is male or female, 4090 years of age, inclusive. 2. Subject has a diagnosis of CRC, at any stage, confirmed with a tissue biopsy and/or â‰¥1 cm colorectal polyp/adenoma/mass identified on a colonoscopy that is of sufficient size to require surgical excision or complex colonoscopic polypectomy. 3. Subject understands the study procedures and is able to provide informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigator. 1. Subject has active synchronous extracolonic aerodigestive tract cancers (e.g., lung, esophagus, stomach, or pancreatic cancer). 2. Subject has a history of any inflammatory bowel disease. 3. Subject has familial adenomatous polyposis, hereditary nonpolyposis colorectal cancer (Lynch) syndrome, or other hereditary cancer syndromes. 4. Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Neoplasm</keyword>
	<keyword>Colorectal Neoplasm</keyword>
	<keyword>Intestinal Neoplasms</keyword>
	<keyword>Gastrointestinal Neoplasms</keyword>
	<keyword>Digestive System Neoplasms</keyword>
	<keyword>Neoplasms by Site</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Digestive System Diseases</keyword>
	<keyword>Gastrointestinal Diseases</keyword>
	<keyword>Colonic Diseases</keyword>
	<keyword>Intestinal Diseases</keyword>
	<keyword>Rectal Diseases</keyword>
</DOC>